Drug profile · INN
linezolid
LINEZOLID
linezolid (LINEZOLID) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — linezolid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 10
- Data quality
- 0.89
Quick answer
linezolid (LINEZOLID) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is linezolid?
linezolid (LINEZOLID) is a bacterial 70s ribosome inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for linezolid?
LINEZOLID is a marketed brand name for linezolid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of linezolid?
linezolid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.